Tech

October 12, 2012

NASA signs agreement to develop nasal spray for motion sickness

NASA’s Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With

precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

 




All of this week's top headlines to your email every Friday.


 
 

 

Headlines August 22, 2014

News: GAO: Pentagon violated law with Bergdahl swap - Congressional investigators say the Pentagon violated the law when it swapped five Taliban leaders for Army Sgt. Bowe Bergdahl, who was held prisoner in Afghanistan for five years.   Business: U.S. Air Force issues RFI for new rocket engine - The US Air Force is officially looking into...
 
 

News Briefs August 22, 2014

U.S. military deaths in Afghanistan at 2,200 As of Aug. 20, 2014, at least 2,200 members of the U.S. military had died in Afghanistan as a result of the U.S.-led invasion of Afghanistan in late 2001, according to an Associated Press count. At least 1,821 military service members have died in Afghanistan as a result...
 
 
navair-triton

MQ-4C Tritons to arrive at Pax River this fall

  MQ-4C Triton test air vehicles at Northrop Grumman’s facility in Palmdale, Calif., will fly cross-country to Naval Air Station Patuxent River, Md., this fall. The MQ-4C completed a test flight Aug. 19 with updated ...
 

 
Boeing photograph

Boeing program completes critical design, safety reviews

Boeing photograph Boeing recently completed the Phase Two Spacecraft Safety Review of its Crew Space Transportation-100 spacecraft and the Critical Design Review of its integrated systems, meeting all of the companyís Commerci...
 
 
global-hawk2

Air Combat Command loans Global Hawk to GVCTF

Air Force photograph by Jennifer Romo The 412th Test Wing’s Global Vigilance Combined Test Force received a Global Hawk Block 40 Aug. 6, on loan from Air Combat Command. Tail number 2035, from Grand Forks AFB, N.D., is jo...
 
 

NASA awards program analysis, Control Bridge III Contract

NASA has awarded the Program Analysis and Control III Bridge contract for support services to ASRC Research & Technology Solutions of Beltsville, Md. The cost-plus-fixed-fee, indefinite delivery/indefinite quantity basic contract has a minimum ordering value of $1 million and a maximum ordering value of $37 million, with a performance period beginning Aug. 30 through Feb....
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>